Stock Information

Kingchem Life Science was founded in 1994 and became a public company trading on the Shenzhen Stock Exchange on August 3, 2023. Kingchem Life Science, through its family of companies with production and R&D services in the US and China, is a CDMO offering a wide range of chemical capabilities to the Specialty Chemical, Pharmaceutical, and Agrochemical industries. We specialize in custom manufacturing including fluorination at our plant in Fuxin, China, and cGMP capabilities through our facility in Wisconsin, USA which is focused on API, intermediate, and RSM manufacturing.  Kingchem’s Research & Development teams, based in Dalian China, and Wisconsin, USA, provide integrated and cost-effective process R&D services including design of practical synthesis, improvement of existing chemistry, and development of commercial processes.
 

Stock Information